论文部分内容阅读
目的评价经皮经肝穿刺单侧入路双支架植入术治疗左、右肝管同时受累的肝门部胆管梗阻的疗效和临床价值。方法8例左、右肝内胆管同时受累的肝门部胆管梗阻病人,经皮经右肝或左肝单侧入路,通过在左、右肝管间和肝管、胆总管间植入金属双支架行胆管内引流,并结合抗肿瘤治疗。结果8例16枚支架全部放置成功,术后2周总胆红素由术前的(267.1±154.7)μmol/L下降至(61.2±13.4)μmol/L,无严重并发症及死亡病例。结论左、右肝管同时受累的肝门部胆管梗阻患者行单侧入路双支架植入技术并结合抗肿瘤治疗是一种安全,有效,可靠的治疗肝门部胆管的方法。
Objective To evaluate the efficacy and clinical value of percutaneous transhepatic one-sided double stenting for the treatment of hepatic portal bile duct obstruction involving both left and right hepatic vessels. Methods Eight patients with hilar bile duct obstruction involving the left and right intrahepatic bile ducts at the same time were percutaneously transplanted either by the right or left hepatic artery through the left and right hepatic duct and between the hepatic duct and the common bile duct Double stent biliary drainage, combined with anti-tumor therapy. Results All 16 stents were placed successfully in 8 cases, and the total bilirubin decreased from (267.1 ± 154.7) μmol / L to (61.2 ± 13.4) μmol / L preoperatively 2 weeks after operation. There were no serious complications and deaths. Conclusion Both left and right hepatic duct involvement of hilar bile duct obstruction patients underwent unilateral approach of double stent implantation combined with anti-tumor therapy is a safe, effective and reliable method for the treatment of hilar bile duct.